Beta-lactamase inhibitors
US9926336B2 · kind B2 · utility
9Cited by
11References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2017 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Aug 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.